AAX Biotech AB
|
Website:
aaxbiotech.com |
|
|
Headquarters:
Stockholm, , SE |
|
|
Company Type:
New Startup (0-1M TTM Revenue) |
AAX Biotech AB is a research-driven biotech company with proprietary technologies that solve unmet needs in the development of next-generation antibody therapeutics. The company provides two unique technologies:
- Seqitope: an epitope mapping technology with single amino acid resolution and high-throughput capabilities.
- Opti-mAb: a universal stabilization strategy for single-chain variable fragments (scFv) designed for applications such as bispecific antibodies and CAR-T cells.
| Site | Badges | |
|---|---|---|
| AAX Biotech AB c/o Stiftelsen CMM, Visionsgatan 18, L8:01 Stockholm, , 171 76 Sweden | ||
| AAX Biotech AB c/o Stiftelsen CMM, Visionsgatan 18, L8:01 Stockholm, , 171 76 Sweden | ||
Get started
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order products instantly, request access below.